Ono Pharmaceutical Past Earnings Performance
Past criteria checks 3/6
Ono Pharmaceutical has been growing earnings at an average annual rate of 18.8%, while the Pharmaceuticals industry saw earnings growing at 3.6% annually. Revenues have been growing at an average rate of 12.4% per year. Ono Pharmaceutical's return on equity is 16.2%, and it has net margins of 25.6%.
Key information
18.8%
Earnings growth rate
20.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 3.4% |
| Revenue growth rate | 12.4% |
| Return on equity | 16.2% |
| Net Margin | 25.6% |
| Next Earnings Update | 09 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Ono Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 498,070 | 127,611 | 93,791 | 105,863 |
| 30 Sep 23 | 489,199 | 124,875 | 91,302 | 105,076 |
| 30 Jun 23 | 460,481 | 115,064 | 88,400 | 100,510 |
| 31 Mar 23 | 447,187 | 112,723 | 86,643 | 95,344 |
| 31 Dec 22 | 428,951 | 111,555 | 82,778 | 92,389 |
| 30 Sep 22 | 403,985 | 96,568 | 79,408 | 82,955 |
| 30 Jun 22 | 380,720 | 85,922 | 76,890 | 80,047 |
| 31 Mar 22 | 361,361 | 80,519 | 74,119 | 75,879 |
| 31 Dec 21 | 345,781 | 73,558 | 75,888 | 68,001 |
| 30 Sep 21 | 332,887 | 81,866 | 74,455 | 69,203 |
| 30 Jun 21 | 321,734 | 78,003 | 71,372 | 65,286 |
| 31 Mar 21 | 309,284 | 75,425 | 66,616 | 62,384 |
| 31 Dec 20 | 302,054 | 74,364 | 62,474 | 64,973 |
| 30 Sep 20 | 293,886 | 66,737 | 61,279 | 61,295 |
| 30 Jun 20 | 293,351 | 64,870 | 62,822 | 62,874 |
| 31 Mar 20 | 292,420 | 59,704 | 65,196 | 66,497 |
| 31 Dec 19 | 290,736 | 60,233 | 66,771 | 64,207 |
| 30 Sep 19 | 293,247 | 55,510 | 67,528 | 67,895 |
| 30 Jun 19 | 291,374 | 52,633 | 67,548 | 70,264 |
| 31 Mar 19 | 288,634 | 51,539 | 68,000 | 70,008 |
| 31 Dec 18 | 284,463 | 51,978 | 69,043 | 71,627 |
| 30 Sep 18 | 284,785 | 57,919 | 67,967 | 70,453 |
| 30 Jun 18 | 272,165 | 53,746 | 67,138 | 69,593 |
| 31 Mar 18 | 261,836 | 50,284 | 66,353 | 68,821 |
| 31 Dec 17 | 256,522 | 54,760 | 64,978 | 66,892 |
| 30 Sep 17 | 248,517 | 53,884 | 63,966 | 63,599 |
| 30 Jun 17 | 246,953 | 53,887 | 62,846 | 61,325 |
| 31 Mar 17 | 244,797 | 55,793 | 60,660 | 57,506 |
| 31 Dec 16 | 236,710 | 48,270 | 57,396 | 52,949 |
| 30 Sep 16 | 207,707 | 36,225 | 53,702 | 49,595 |
| 30 Jun 16 | 183,345 | 29,206 | 49,850 | 46,653 |
| 31 Mar 16 | 160,284 | 24,979 | 42,628 | 43,369 |
| 31 Dec 15 | 140,927 | 16,449 | 38,705 | 40,751 |
| 30 Sep 15 | 143,697 | 21,568 | 37,113 | 40,790 |
| 30 Jun 15 | 139,663 | 19,521 | 36,244 | 39,972 |
| 31 Mar 15 | 135,775 | 12,976 | 40,824 | 41,346 |
| 31 Dec 14 | 137,592 | 17,663 | 42,572 | 38,204 |
| 30 Sep 14 | 133,926 | 13,474 | 41,296 | 39,463 |
| 30 Jun 14 | 137,146 | 16,787 | 39,685 | 40,895 |
| 31 Mar 14 | 143,247 | 20,350 | 36,900 | 44,413 |
| 31 Dec 13 | 145,946 | 21,574 | 35,552 | 49,229 |
| 30 Sep 13 | 145,984 | 23,205 | 35,094 | 49,203 |
| 30 Jun 13 | 145,650 | 22,170 | 35,094 | 48,619 |
Quality Earnings: 4528 has high quality earnings.
Growing Profit Margin: 4528's current net profit margins (25.6%) are lower than last year (26%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4528's earnings have grown by 18.8% per year over the past 5 years.
Accelerating Growth: 4528's earnings growth over the past year (14.4%) is below its 5-year average (18.8% per year).
Earnings vs Industry: 4528 earnings growth over the past year (14.4%) exceeded the Pharmaceuticals industry -2.9%.
Return on Equity
High ROE: 4528's Return on Equity (16.2%) is considered low.